Islanders bench star Mathew Barzal for late arrival, emphasizing team culture and accountability.
Eagles trade for Jets CB Michael Carter II, bolstering their secondary depth
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Islanders bench star Mathew Barzal for late arrival, emphasizing team culture and accountability.
Eagles trade for Jets CB Michael Carter II, bolstering their secondary depth
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.